PLUS1
33.85
0.02 (0.06%)
0.02 (0.06%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Pfizer Inc | PFE | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.37 | 1.11% | 33.83 | 33.485 | 34.04 | 33.66 | 33.46 | 20:00:00 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 100,436 | 23,206,872 | $ 33.72 | $ 782,586,036 | 34,227,801 | 8.00 - 44.21 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:29 | formt | 200 | $ 33.85 | USD |
Pfizer Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 187.92B | 5.55B | 5.55B | $ 51.75B | $ 14.92B | 2.88 | 12.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 53.75M | $ 1.44 | 4.26% | - | - |
Pfizer News
| Date | Time | Source | News Article |
|---|---|---|---|
| 7/10/2020 | 18:33 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 7/10/2020 | 18:33 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 7/10/2020 | 18:33 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 7/09/2020 | 15:46 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) |
| 7/09/2020 | 09:03 | Business Wire | Pfizer Pledges $100 Million to New Industry Fund to Help.. |
| 7/05/2020 | 18:43 | Dow Jones News | Correction to Poor Performance of Health-Care Stocks Article |
| 7/05/2020 | 17:17 | Dow Jones News | Coronavirus Is No Cure for Health-Care Stocks |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PFE Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 34.95 | 35.35 | 33.101 | 33.99 | 22,963,631 | -1.12 | -3.2% |
| 1 Month | 34.08 | 35.35 | 31.61 | 33.34 | 32,886,179 | -0.25 | -0.73% |
| 3 Months | 36.40 | 39.50 | 31.61 | 35.48 | 28,453,492 | -2.57 | -7.06% |
| 6 Months | 39.01 | 40.97 | 27.88 | 34.89 | 30,852,860 | -5.18 | -13.28% |
| 1 Year | 43.65 | 44.21 | 8.00 | 36.06 | 26,134,720 | -9.82 | -22.5% |
| 3 Years | 33.36 | 46.47 | 8.00 | 37.95 | 21,595,498 | 0.47 | 1.41% |
| 5 Years | 34.24 | 46.47 | 8.00 | 35.60 | 23,310,783 | -0.41 | -1.2% |
Pfizer Description
| Pfizer is one of the world's largest pharmaceutical firms, with annual sales over $50 billion. Pfizer also spends a leading amount on research and development, close to $8 billion annually. While Pfizer historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, neuroscience drug Lyrica, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor, representing over a fifth of total firm sales. |
